{"title":"Long-term dopamine receptor blockade not linked to psychotic relapse","authors":"","doi":"10.1002/pu.31308","DOIUrl":null,"url":null,"abstract":"<p>A cohort study has found that long-term use of dopamine D2 receptor antagonists was not associated with increased risk of breakthrough psychosis in patients with first-episode schizophrenia. Risk of relapse within the cohort decreased over time, the investigators reported. Study results were published online Feb. 19, 2025, in the <i>American Journal of Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 6","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31308","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A cohort study has found that long-term use of dopamine D2 receptor antagonists was not associated with increased risk of breakthrough psychosis in patients with first-episode schizophrenia. Risk of relapse within the cohort decreased over time, the investigators reported. Study results were published online Feb. 19, 2025, in the American Journal of Psychiatry.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
